Hemospray for recurrent esophageal band ulcer bleeding

Uday A. Sanglodkar; Dinesh Jothimani; Mohamed Rela

doi:10.5114/ceh.2018.73668

eISSN: 2449-8238
ISSN: 2392-1099

Clinical and Experimental Hepatology

Current issue Archive Manuscripts accepted About the journal Editorial board Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2018
vol. 4

Send email

Copy url:

abstract:

Case report

Hemospray for recurrent esophageal band ulcer bleeding

Uday A. Sanglodkar

,

Dinesh Jothimani

,

Mohamed Rela

Clin Exp HEPATOL 2018; 4, 1: 46-48

DOI: https://doi.org/10.5114/ceh.2018.73668

Online publish date: 2018/02/10

View full text Get citation

PlumX metrics:

Rebleeding after initially successful endoscopic variceal ligation (EVL) occurs in 20-60% of patients, most commonly from band ulcers, and is associated with 20-50% mortality. Although band ulcer bleeding has been treated in a number of different ways, no single therapeutic intervention has shown a clear benefit. Hemospray (Cook Medical, Winston-Salem, North Carolina, USA) is a relatively new non-contact hemostatic modality used in the management of bleeding peptic ulcers. It is a nano-powder that can be sprayed over a larger mucosal area. Here we describe a patient with end stage liver disease who presented with recurrent bleeding from a deep esophageal ulcer following band ligation and sclerotherapy, effectively managed with multiple sessions of Hemospray.

keywords:

Hemospray for recurrent esophageal band ulcer bleeding

Uday A. Sanglodkar , Dinesh Jothimani , Mohamed Rela

ulcer, esophageal varices, esophagogastroduodenoscopy, Hemospray

Uday A. Sanglodkar

,

Dinesh Jothimani

,

Mohamed Rela